Items where authors include "Curigliano, G."

Article

Lee, M., Larose, H. orcid.org/0000-0003-4678-6048, Gräbeldinger, M. et al. (20 more authors) (2024) The evolving value assessment of cancer therapies: Results from a modified Delphi study. Health Policy OPEN, 6. 100116. ISSN 2590-2296

Saini, K.S., Lanza, C., Romano, M. et al. (10 more authors) (2020) Repurposing anticancer drugs for COVID-19-induced inflammation, immune dysfunction, and coagulopathy. British Journal of Cancer, 123. pp. 694-697. ISSN 0007-0920

Kovacs, T., Rubio, I., Markopoulos, C. et al. (31 more authors) (2020) European breast surgical oncology certification theoretical and practical knowledge curriculum 2020. European Journal of Surgical Oncology, 46 (4 Part B). pp. 717-736. ISSN 0748-7983

Proceedings Paper

Goetz, M.P., Wander, S.A., Bachelot, T. et al. (17 more authors) (2024) Open-label, randomized, multicenter, phase 3, ELAINE 3 study of the efficacy and safety of lasofoxifene plus abemaciclib for treating ER+/HER2-, locally advanced or metastatic breast cancer with an ESR1 mutation. In: Journal of Clinical Oncology. 2024 ASCO Annual Meeting, 31 May - 04 Jun 2024, Chicago, USA. American Society of Clinical Oncology .

Lee, M., Abrams, K., Baird, A.M. et al. (17 more authors) (2023) EHTA307 Evolving Principles for Defining and Assessing the Economic and Societal Value of Cancer Therapies. In: Value in Health. ISPOR Europe 2023, 11-15 Nov 2023. , S380-S380.

Lee, M., Abrams, K., Baird, A.M. et al. (17 more authors) (2023) HTA307 Evolving Principles for Defining and Assessing the Economic and Societal Value of Cancer Therapies. In: Value in Health. ISPOR Europe 2023, 11-15 Nov 2023, Copenhagen, Denmark. Elsevier , s380-s380.

Lee, M., Baird, A.-M., Brown, S. et al. (17 more authors) (2023) The evolving value assessment of cancer therapies: Principles from the cancer community. In: Journal of Clinical Oncology. 2023 ASCO Annual Meeting I, 02-06 Jun 2023, Chicago, IL. American Society of Clinical Oncology , Alexandria, Virginia, USA .